I particularly like this bit....
“The CLTX CAR T dose escalation preliminary data are truly encouraging and have exceeded our
expectations, particularly given that the patients enrolled were heavily pretreated and very late
stage,” said Jennifer Chow, CEO and Managing Director of Chimeric Therapeutics.
- Forums
- ASX - By Stock
- Ann: New data for Phase 1A CLTX CAR T brain cancer clinical trial
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

I particularly like this bit....“The CLTX CAR T dose escalation...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
26 | 21888206 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 28746371 | 29 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
26 | 21888206 | 0.004 |
37 | 23631939 | 0.003 |
15 | 13500507 | 0.002 |
9 | 49600000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 28746371 | 29 |
0.006 | 13797410 | 17 |
0.007 | 4750000 | 5 |
0.008 | 8542434 | 6 |
0.009 | 3727673 | 6 |
Last trade - 10.21am 17/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online